{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:50:57Z","timestamp":1791661857887,"version":"4.3.4"},"reference-count":174,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021783","name":"Courtois Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021783","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.cellsig.2026.112926","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:38:35Z","timestamp":1791319115000},"page":"112926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bridging the gap: combining GPCR-based drug discovery with iPSC-based cardiovascular disease modeling in a dish"],"prefix":"10.1016","volume":"149","author":[{"given":"Diego","family":"Loggia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Castagnola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence E.","family":"H\u00e9bert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cellsig.2026.112926_bb0005","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.bbamem.2007.02.010","article-title":"Cardiac GPCRs: GPCR signaling in healthy and failing hearts","volume":"1768","author":"Salazar","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112926_bb0010","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/CIRCRESAHA.118.311403","article-title":"G-Protein\u2013Coupled Receptors in Heart Disease","volume":"123","author":"Wang","year":"2018","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0015","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/CIRCRESAHA.124.323067","article-title":"G Protein-Coupled Receptors: A Century of Research and Discovery","volume":"135","author":"Liu","year":"2024","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112926_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.0020013","article-title":"Structure Modeling of All Identified G Protein\u2013Coupled Receptors in the Human Genome","volume":"2","author":"Zhang","year":"2006","journal-title":"PLoS Comput. Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112926_bb0025","first-page":"C731","article-title":"G protein-coupled receptor signaling: transducers and effectors","volume":"323","author":"Jiang","year":"2022","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112926_bb0030","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cels.2021.02.001","article-title":"Diversity of the G\u03b2\u03b3 complexes defines spatial and temporal bias of GPCR signaling","volume":"12","author":"Masuho","year":"2021","journal-title":"Cell Syst"},{"key":"10.1016\/j.cellsig.2026.112926_bb0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev-pharmtox-061008-103038","article-title":"The role of G\u03b2\u03b3 subunits in the organization, assembly, and function of GPCR signaling complexes","volume":"49","author":"Dupr\u00e9","year":"2009","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112926_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102618","article-title":"G protein \u03b3 subunit, a hidden master regulator of GPCR signaling","volume":"298","author":"Kankanamge","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112926_bb0045","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1124\/pr.111.005603","article-title":"The expanding roles of G\u03b2\u03b3 subunits in G protein-coupled receptor signaling and drug action","volume":"65","author":"Khan","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cellsig.2026.112926_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108589","article-title":"Non-canonical G protein signaling","volume":"255","author":"N\u00fcrnberg","year":"2024","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cellsig.2011.08.014","article-title":"Non-canonical signaling and localizations of heterotrimeric G proteins","volume":"24","author":"Hewavitharana","year":"2012","journal-title":"Cell. Signal."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112926_bb0060","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/FJC.0000000000000482","article-title":"G Protein-Coupled Receptor Signaling Through \u03b2-Arrestin-Dependent Mechanisms","volume":"70","author":"Jean-Charles","year":"2017","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112926_bb0065","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.tips.2011.05.002","article-title":"\u03b2-Arrestin-mediated receptor trafficking and signal transduction","volume":"32","author":"Shenoy","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"issue":"17","key":"10.1016\/j.cellsig.2026.112926_bb0070","doi-asserted-by":"crossref","first-page":"8969","DOI":"10.1074\/jbc.R115.713313","article-title":"The \u03b2-Arrestins: Multifunctional Regulators of G Protein-coupled Receptors","volume":"291","author":"Smith","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112926_bb0075","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41573-025-01139-y","article-title":"GPCR drug discovery: new agents, targets and indications","volume":"24","author":"Lorente","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112926_bb0080","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/01.RES.0000102042.83024.CA","article-title":"What Is the Role of \u03b2-Adrenergic Signaling in Heart Failure?","volume":"93","author":"Lohse","year":"2003","journal-title":"Circ. Res."},{"issue":"15","key":"10.1016\/j.cellsig.2026.112926_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158507","article-title":"Functional Characterization of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells","volume":"23","author":"Fan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112926_bb0095","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.stemcr.2014.09.002","article-title":"Aberrant \u03b1-adrenergic hypertrophic response in cardiomyocytes from human induced pluripotent cells","volume":"3","author":"F\u00f6ldes","year":"2014","journal-title":"Stem Cell Reports"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112926_bb0100","doi-asserted-by":"crossref","first-page":"H725","DOI":"10.1152\/ajpheart.00621.2020","article-title":"Cardiac \u03b11A-adrenergic receptors: emerging protective roles in cardiovascular diseases","volume":"320","author":"Zhang","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"Pt A","key":"10.1016\/j.cellsig.2026.112926_bb0105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.phrs.2017.05.008","article-title":"AT1 receptor signaling pathways in the cardiovascular system","volume":"125","author":"Kawai","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"125","key":"10.1016\/j.cellsig.2026.112926_bb0110","doi-asserted-by":"crossref","first-page":"ra46","DOI":"10.1126\/scisignal.2000769","article-title":"\u03b2-Arrestin-biased agonism of the angiotensin receptor induced by mechanical stress","volume":"3","author":"Rakesh","year":"2010","journal-title":"Sci. Signal."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112926_bb0115","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/FJC.0000000000000208","article-title":"AT2 receptor activities and pathophysiological implications","volume":"65","author":"Matavelli","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112926_bb0120","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1161\/HYPERTENSIONAHA.120.11941","article-title":"Angiotensin II Type 2 Receptor: A Target for Protection Against Hypertension, Metabolic Dysfunction, and Organ Remodeling","volume":"77","author":"Fatima","year":"2021","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112926_bb0125","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s003950170003","article-title":"Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart","volume":"96","author":"Brodde","year":"2001","journal-title":"Basic Res. Cardiol."},{"issue":"Suppl. 1","key":"10.1016\/j.cellsig.2026.112926_bb0130","doi-asserted-by":"crossref","first-page":"S389","DOI":"10.33549\/physiolres.935270","article-title":"Muscarinic Receptors in Cardioprotection and Vascular Tone Regulation","volume":"73","author":"Dolej\u0161\u00ed","year":"2024","journal-title":"Physiol. Res."},{"issue":"6102","key":"10.1016\/j.cellsig.2026.112926_bb0135","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/325321a0","article-title":"The \u03b2\u03b3 subunits of GTP-binding proteins activate the muscarinic K+ channel in heart","volume":"325","author":"Logothetis","year":"1987","journal-title":"Nature"},{"issue":"6571","key":"10.1016\/j.cellsig.2026.112926_bb0140","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/380255a0","article-title":"Voltage-dependent modulation of N-type calcium channels by G-protein \u03b2\u03b3 subunits","volume":"380","author":"Ikeda","year":"1996","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112926_bb0145","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0031-6997(24)01425-X","article-title":"Adrenergic and muscarinic receptors in the human heart","volume":"51","author":"Brodde","year":"1999","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physiolgenomics.00062.2017","article-title":"Distribution and function of the muscarinic receptor subtypes in the cardiovascular system","volume":"50","author":"Saternos","year":"2018","journal-title":"Physiol. Genomics"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0155","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/01.CIR.88.1.43","article-title":"Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans","volume":"88","author":"Lefroy","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.cellsig.2026.112926_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.155932","article-title":"The role of endothelin and its receptors in cardiomyopathy: From molecular mechanisms to therapeutic insights","volume":"269","author":"Dubey","year":"2025","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0165","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/cvr\/cvq125","article-title":"Endothelin signalling regulates volume-sensitive Cl\u2212 current via NADPH oxidase and mitochondrial reactive oxygen species","volume":"88","author":"Deng","year":"2010","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112926_bb0170","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1161\/CIRCRESAHA.112.273896","article-title":"Cardiotoxic and Cardioprotective Features of Chronic \u03b2-Adrenergic Signaling","volume":"112","author":"Zhang","year":"2013","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112926_bb0175","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0008-6363(02)00729-0","article-title":"Chronic \u03b22-adrenergic receptor stimulation increases proliferation of human cardiac fibroblasts via an autocrine mechanism","volume":"57","author":"Turner","year":"2003","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112926_bb0090","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJM198207223070401","article-title":"Decreased Catecholamine Sensitivity and \u03b2-Adrenergic-Receptor Density in Failing Human Hearts","volume":"307","author":"Bristow Michael","year":"1982","journal-title":"N. Engl. J. Med."},{"issue":"2 Pt 2","key":"10.1016\/j.cellsig.2026.112926_bb0180","first-page":"H707","article-title":"Adenylyl cyclase and G protein receptor kinase expression during development of heart failure","volume":"273","author":"Ping","year":"1997","journal-title":"Am. J. Phys."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112926_bb0185","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1161\/01.RES.74.2.206","article-title":"Expression of \u03b2-arrestins and \u03b2-adrenergic receptor kinases in the failing human heart","volume":"74","author":"Ungerer","year":"1994","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112926_bb0190","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/01.CIR.87.2.454","article-title":"Altered expression of \u03b2-adrenergic receptor kinase and \u03b21-adrenergic receptors in the failing human heart","volume":"87","author":"Ungerer","year":"1993","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112926_bb0195","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0163-7258(93)90030-H","article-title":"\u03b2-adrenoceptors in cardiac disease","volume":"60","author":"Brodde","year":"1993","journal-title":"Pharmacol. Ther."},{"issue":"8617","key":"10.1016\/j.cellsig.2026.112926_bb0200","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(88)92601-3","article-title":"Increase in myocardial Gi-proteins in heart failure","volume":"2","author":"Neumann","year":"1988","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112926_bb0205","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/01.CIR.82.4.1249","article-title":"Increase of Gi\u03b1 in human hearts with dilated but not ischemic cardiomyopathy","volume":"82","author":"B\u00f6hm","year":"1990","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112926_bb0210","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2125.2005.02438.x","article-title":"The functional significance of genetic variation within the \u03b2-adrenoceptor","volume":"60","author":"Sandilands","year":"2005","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0215","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1476-5381.2009.00187.x","article-title":"\u03b21- and \u03b22-adrenoceptor polymorphisms and cardiovascular diseases","volume":"158","author":"Leineweber","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"34","key":"10.1016\/j.cellsig.2026.112926_bb0220","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M200681200","article-title":"The myocardium-protective Gly-49 variant of the \u03b21-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation","volume":"277","author":"Levin","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112926_bb0225","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/01213011-200504000-00006","article-title":"\u03b21-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to \u03b2-blocker therapy","volume":"15","author":"Terra","year":"2005","journal-title":"Pharmacogenet. Genomics"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0230","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejheart.2007.11.008","article-title":"Role of \u03b2 adrenergic receptor polymorphisms in heart failure: Systematic review and meta-analysis","volume":"10","author":"Muthumala","year":"2008","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.cellsig.2026.112926_bb0235","series-title":"\u03b11-Adrenergic Receptor Subtypes in Nonfailing and Failing Human Myocardium","first-page":"654","volume":"2","author":"Jensen","year":"2009"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112926_bb0240","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/FJC.0000000000000032","article-title":"\u03b11-adrenergic receptors in heart failure: the adaptive arm of the cardiac response to chronic catecholamine stimulation","volume":"63","author":"Jensen","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112926_bb0245","series-title":"Molecular and cellular mechanisms of cardiovascular regulation","author":"Endoh","year":"2013"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112926_bb0250","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0022-3565(24)36448-1","article-title":"Comparison between \u03b11 adrenoceptor-mediated and \u03b2 adrenoceptor-mediated inotropic components elicited by norepinephrine in failing human ventricular muscle","volume":"280","author":"Skomedal","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112926_bb0255","first-page":"H931","article-title":"Cardiac-directed overexpression of wild-type \u03b11B-adrenergic receptor induces dilated cardiomyopathy","volume":"281","author":"Lemire","year":"2001","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0260","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0008-6363(00)00008-0","article-title":"Type 2 angiotensin II receptor is downregulated in cardiomyocytes of patients with heart failure","volume":"46","author":"Matsumoto","year":"2000","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112926_bb0265","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1161\/01.CIR.95.5.1201","article-title":"AT1 and AT2 angiotensin receptor gene expression in human heart failure","volume":"95","author":"Haywood","year":"1997","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112926_bb0270","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/01.HYP.0000222893.85662.cd","article-title":"Angiotensin Type-1 Receptor A1166C Gene Polymorphism Correlates With Oxidative Stress Levels in Human Heart Failure","volume":"47","author":"Cameron","year":"2006","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112926_bb0275","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ihj.2015.04.013","article-title":"Role of angiotensin II type I (AT1 A1166C) receptor polymorphism in susceptibility of left ventricular dysfunction","volume":"67","author":"Mishra","year":"2015","journal-title":"Indian Heart J."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0280","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(99)00261-7","article-title":"Muscarinic receptors in the failing human heart","volume":"375","author":"Giessler","year":"1999","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112926_bb0285","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1161\/01.CIR.96.10.3416","article-title":"Increased Myocardial Muscarinic Receptor Density in Idiopathic Dilated Cardiomyopathy","volume":"96","author":"Le Guludec","year":"1997","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.cellsig.2026.112926_bb0290","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1161\/CIRCULATIONAHA.122.063327","article-title":"Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HF","volume":"147","author":"Yeoh","year":"2023","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.cellsig.2026.112926_bb0295","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/0002-9149(93)90543-L","article-title":"Plasma big endothelin-1 concentrations in congestive heart failure patients with or without systemic hypertension","volume":"71","author":"Pacher","year":"1993","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112926_bb0300","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1142\/S0192415X18500623","article-title":"Oleanolic Acid, a Novel Endothelin A Receptor Antagonist, Alleviated High Glucose-Induced Cardiomyocytes Injury","volume":"46","author":"Wu","year":"2018","journal-title":"Am J Chin Med"},{"issue":"22","key":"10.1016\/j.cellsig.2026.112926_bb0305","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/CIRCULATIONAHA.110.938217","article-title":"Endothelial Cell\u2013Derived Endothelin-1 Promotes Cardiac Fibrosis in Diabetic Hearts Through Stimulation of Endothelial-to-Mesenchymal Transition","volume":"121","author":"Widyantoro","year":"2010","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0310","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/01.RES.69.1.209","article-title":"Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes","volume":"69","author":"Ito","year":"1991","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112926_bb0315","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/01.CIR.0000105701.98663.D4","article-title":"Conditional Cardiac Overexpression of Endothelin-1 Induces Inflammation and Dilated Cardiomyopathy in Mice","volume":"109","author":"Yang","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0320","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12872-023-03658-1","article-title":"Activation of ETAR and ETBR in myocardial tissue characterizes heart failure induced by experimental autoimmune myocarditis","volume":"24","author":"Yang","year":"2024","journal-title":"BMC Cardiovasc. Disord."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112926_bb0325","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1161\/CIRCRESAHA.110.217075","article-title":"Small molecule disruption of G\u03b2\u03b3 signaling inhibits the progression of heart failure","volume":"107","author":"Casey","year":"2010","journal-title":"Circ. Res."},{"issue":"23","key":"10.1016\/j.cellsig.2026.112926_bb0330","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/j.jacc.2014.02.587","article-title":"Simultaneous adrenal and cardiac G-protein-coupled receptor-G\u03b2\u03b3 inhibition halts heart failure progression","volume":"63","author":"Kamal","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112926_bb0335","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jacc.2017.06.049","article-title":"Pharmacological and Activated Fibroblast Targeting of G\u03b2\u03b3-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression","volume":"70","author":"Travers","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112926_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.103064","article-title":"G\u03b2\u03b3 subunits colocalize with RNA polymerase II and regulate transcription in cardiac fibroblasts","volume":"299","author":"Khan","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112926_bb0345","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/hc1102.105270","article-title":"Propranolol prevents the development of heart failure by restoring FKBP12.6-mediated stabilization of ryanodine receptor","volume":"105","author":"Doi","year":"2002","journal-title":"Circulation"},{"issue":"9377","key":"10.1016\/j.cellsig.2026.112926_bb0350","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial","volume":"362","author":"Poole-Wilson","year":"2003","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112926_bb0355","doi-asserted-by":"crossref","first-page":"e2529519","DOI":"10.1001\/jamanetworkopen.2025.29519","article-title":"\u03b2-Blocker Use and Health Status Among Patients With Heart Failure With Preserved Ejection Fraction","volume":"8","author":"Abdel Jawad","year":"2025","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0360","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jacbts.2016.10.006","article-title":"An Oral Selective \u03b11A Adrenergic Receptor Agonist Prevents Doxorubicin Cardiotoxicity","volume":"2","author":"Beak","year":"2017","journal-title":"JACC Basic. Transl. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168409","article-title":"An \u03b11A Adrenergic Receptor Agonist Prevents Acute Doxorubicin Cardiomyopathy in Male Mice","volume":"12","author":"Montgomery","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112926_bb0370","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nrcardio.2012.196","article-title":"Targeting the renin-angiotensin-aldosterone system in heart failure","volume":"10","author":"Lang","year":"2013","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112926_bb0375","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/HYPERTENSIONAHA.120.16667","article-title":"Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study","volume":"78","author":"Chen","year":"2021","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0380","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7326\/0003-4819-148-1-200801010-00189","article-title":"Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension","volume":"148","author":"Matchar","year":"2008","journal-title":"Ann. Intern. Med."},{"issue":"15","key":"10.1016\/j.cellsig.2026.112926_bb0385","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"or Both in Patients at High Risk for Vascular Events","volume":"358","author":"Telmisartan","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.cellsig.2026.112926_bb0390","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for Heart Failure with Preserved Ejection Fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112926_bb0395","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1096\/fasebj.4.6.2156744","article-title":"Effect of carbachol and cyclic GMP on susceptibility to ventricular fibrillation","volume":"4","author":"Billman","year":"1990","journal-title":"FASEB J."},{"key":"10.1016\/j.cellsig.2026.112926_bb0400","series-title":"Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure","first-page":"317","volume":"5(5)","author":"Packer","year":"2017"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112926_bb0405","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jchf.2013.12.002","article-title":"Randomized, double-blind, placebo-controlled study of sitaxsentan to improve impaired exercise tolerance in patients with heart failure and a preserved ejection fraction","volume":"2","author":"Zile","year":"2014","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0410","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cardfail.2004.05.006","article-title":"Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study","volume":"11","author":"Packer","year":"2005","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.cellsig.2026.112926_bb0415","series-title":"Dual Endothelin-A\/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction","volume":"9(11)","author":"Valero-Munoz","year":"2016"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112926_bb0420","doi-asserted-by":"crossref","DOI":"10.1111\/fcp.70006","article-title":"Dual ETA-ETB receptor antagonism improves metabolic syndrome-induced heart failure with preserved ejection fraction","volume":"39","author":"Lockwood","year":"2025","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112926_bb0425","doi-asserted-by":"crossref","DOI":"10.31083\/RCM45417","article-title":"Endothelin as a Treatment Target in Cardiovascular Diseases: A Recent Step Forward","volume":"26","author":"Cole","year":"2025","journal-title":"Rev. Cardiovasc. Med."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112926_bb0430","first-page":"e536","article-title":"Aprocitentan: The First Endothelin Receptor Antagonist for Resistant Hypertension","volume":"32","author":"Nguyen","year":"2025","journal-title":"Am. J. Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0435","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010210","article-title":"Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives","volume":"19","author":"Wdowiak","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112926_bb0440","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112926_bb0445","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.cellsig.2026.112926_bb0450","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1007\/s00204-021-03172-3","article-title":"Recent progress of iPSC technology in cardiac diseases","volume":"95","author":"Funakoshi","year":"2021","journal-title":"Arch. Toxicol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112926_bb0455","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nm.4087","article-title":"Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity","volume":"22","author":"Burridge","year":"2016","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112926_bb0460","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23063199","article-title":"Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs)","volume":"23","author":"Narkar","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112926_bb0465","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1021\/acs.chemrestox.1c00203","article-title":"Cardiotoxicity Hazard and Risk Characterization of ToxCast Chemicals Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes from Multiple Donors","volume":"34","author":"Burnett","year":"2021","journal-title":"Chem. Res. Toxicol."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112926_bb0470","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1017\/S0963180115000079","article-title":"The flaws and human harms of animal experimentation","volume":"24","author":"Akhtar","year":"2015","journal-title":"Camb. Q. Healthc. Ethics"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112926_bb0475","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/02611929231157756","article-title":"Poor Translatability of Biomedical Research Using Animals - A Narrative Review","volume":"51","author":"Marshall","year":"2023","journal-title":"Altern. Lab. Anim"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112926_bb0480","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41587-021-00815-9","article-title":"Human heart-forming organoids recapitulate early heart and foregut development","volume":"39","author":"Drakhlis","year":"2021","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112926_bb0485","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1016\/j.cell.2021.04.034","article-title":"Cardioids reveal self-organizing principles of human cardiogenesis","volume":"184","author":"Hofbauer","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0490","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1038\/s41467-021-25329-5","article-title":"Self-assembling human heart organoids for the modeling of cardiac development and congenital heart disease","volume":"12","author":"Lewis-Israeli","year":"2021","journal-title":"Nat. Commun."},{"issue":"25","key":"10.1016\/j.cellsig.2026.112926_bb0495","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1016\/j.cell.2023.10.030","article-title":"Multi-chamber cardioids unravel human heart development and cardiac defects","volume":"186","author":"Schmidt","year":"2023","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0500","doi-asserted-by":"crossref","first-page":"7996","DOI":"10.1038\/s41467-024-52221-9","article-title":"Engineered model of heart tissue repair for exploring fibrotic processes and therapeutic interventions","volume":"15","author":"Yang","year":"2024","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112926_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.stemcr.2026.102856","article-title":"A humanized engineered heart tissue platform for cardiotoxicity assessment","volume":"21","author":"Sun","year":"2026","journal-title":"Stem Cell Reports"},{"issue":"19","key":"10.1016\/j.cellsig.2026.112926_bb0510","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910690","article-title":"Three-Dimensional iPSC-Based In Vitro Cardiac Models for Biomedical and Pharmaceutical Research Applications","volume":"25","author":"Bufi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112926_bb0515","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.stem.2026.07.004","article-title":"Cardiopedia-Ligand: A ligand-receptor perturbation atlas of human cardiac organoid function and transcriptional state","volume":"33","author":"Reid","year":"2026","journal-title":"Cell Stem Cell"},{"issue":"18","key":"10.1016\/j.cellsig.2026.112926_bb0520","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810405","article-title":"Fluorescence Spectroscopy of Low-Level Endogenous \u03b2-Adrenergic Receptor Expression at the Plasma Membrane of Differentiating Human iPSC-Derived Cardiomyocytes","volume":"23","author":"Gmach","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0525","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1038\/s41467-023-43999-1","article-title":"A patterned human primitive heart organoid model generated by pluripotent stem cell self-organization","volume":"14","author":"Volmert","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0530","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-39525-4","article-title":"Comparing the signaling and transcriptome profiling landscapes of human iPSC-derived and primary rat neonatal cardiomyocytes","volume":"13","author":"Bourque","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0535","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41420-022-00945-2","article-title":"Losartan protects human stem cell-derived cardiomyocytes from angiotensin II-induced alcoholic cardiotoxicity","volume":"8","author":"Song","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.cellsig.2026.112926_bb0540","series-title":"Angiotensin II induces apoptosis in human induced pluripotent stem cell-derived cardiomyocytes","author":"Gao","year":"2020"},{"key":"10.1016\/j.cellsig.2026.112926_bb0545","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6067096","article-title":"Ion Channel Expression and Characterization in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes","volume":"2018","author":"Zhao","year":"2018","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.cellsig.2026.112926_bb0550","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yjmcc.2024.07.004","article-title":"Endothelin-1 influences mechanical properties and contractility of hiPSC derived cardiomyocytes resulting in diastolic dysfunction","volume":"194","author":"Redwanz","year":"2024","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112926_bb0555","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001263","article-title":"Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes","volume":"3","author":"Tanaka","year":"2014","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112926_bb0560","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12015-014-9582-4","article-title":"Gene and MicroRNA Profiling of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells","volume":"11","author":"Wang","year":"2015","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.cellsig.2026.112926_bb0565","article-title":"Detecting and measuring of GPCR signaling - comparison of human induced pluripotent stem cells and immortal cell lines","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112926_bb0570","article-title":"\u03b2-Adrenergic Receptors: Not Always Outside-In","volume":"41","author":"Dodge-Kafka","year":"2026","journal-title":"Physiology (Bethesda)"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112926_bb0575","doi-asserted-by":"crossref","first-page":"ar60","DOI":"10.1091\/mbc.E22-10-0476","article-title":"On the inference of ERK signaling dynamics from protein biosensor measurements","volume":"34","author":"Rahman","year":"2023","journal-title":"Mol. Biol. Cell"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112926_bb0580","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0955-0674(02)00313-7","article-title":"Live-cell fluorescent biosensors for activated signaling proteins","volume":"14","author":"Hahn","year":"2002","journal-title":"Curr. Opin. Cell Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0585","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nprot.2017.128","article-title":"Live-cell measurements of kinase activity in single cells using translocation reporters","volume":"13","author":"Kudo","year":"2018","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0590","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.263434","article-title":"Quantitative approaches for studying G protein-coupled receptor signalling and pharmacology","volume":"138","author":"Pearce","year":"2025","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0595","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/1087057112457590","article-title":"Multiparameter in vitro assessment of compound effects on cardiomyocyte physiology using iPSC cells","volume":"18","author":"Sirenko","year":"2013","journal-title":"J. Biomol. Screen."},{"issue":"130","key":"10.1016\/j.cellsig.2026.112926_bb0600","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003552","article-title":"Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy","volume":"4","author":"Sun","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112926_bb0605","article-title":"Carvedilol Phenocopies PGC-1\u03b1 Overexpression to Alleviate Oxidative Stress, Mitochondrial Dysfunction and Prevent Doxorubicin-Induced Toxicity in Human iPSC-Derived Cardiomyocytes","volume":"12","author":"Uche","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.cellsig.2026.112926_bb0610","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9109503","article-title":"Antiarrhythmic Effects of Carvedilol and Flecainide in Cardiomyocytes Derived from Catecholaminergic Polymorphic Ventricular Tachycardia Patients","volume":"2018","author":"P\u00f6l\u00f6nen","year":"2018","journal-title":"Stem Cells Int."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112926_bb0615","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1242\/dmm.026823","article-title":"A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses","volume":"9","author":"Preininger","year":"2016","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.cellsig.2026.112926_bb0620","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2025.1524909","article-title":"Pathogenic KCNH2-G53S variant in the PAS domain influences the electrophysiological phenotype in long QT syndrome type 2","volume":"12","author":"Mun","year":"2025","journal-title":"Front. Cardiovasc. Med."},{"issue":"15","key":"10.1016\/j.cellsig.2026.112926_bb0625","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa0908679","article-title":"Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome","volume":"363","author":"Moretti","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112926_bb0630","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/eurheartj\/ehr073","article-title":"Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation","volume":"32","author":"Matsa","year":"2011","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0635","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/19336950.2022.2106025","article-title":"Exploring mutation specific \u03b2 blocker pharmacology of the pathogenic late sodium channel current from patient-specific pluripotent stem cell myocytes derived from long QT syndrome mutation carriers","volume":"16","author":"Comollo","year":"2022","journal-title":"Channels"},{"key":"10.1016\/j.cellsig.2026.112926_bb0640","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3389\/fcell.2020.00761","article-title":"Propranolol Attenuates Late Sodium Current in a Long QT Syndrome Type 3-Human Induced Pluripotent Stem Cell Model","volume":"8","author":"Hirose","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112926_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112005","article-title":"Spatiotemporal profiling of protein kinase A activity in spontaneously beating hiPSC-derived cardiac organoids","volume":"28","author":"Weiser-Bitoun","year":"2025","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112926_bb0650","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/bios7030024","article-title":"Optical Tracking and Digital Quantification of Beating Behavior in Bioengineered Human Cardiac Organoids","volume":"7","author":"Devarasetty","year":"2017","journal-title":"Biosensors"},{"key":"10.1016\/j.cellsig.2026.112926_bb0655","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2024.1367141","article-title":"PIV-MyoMonitor: an accessible particle image velocimetry-based software tool for advanced contractility assessment of cardiac organoids","volume":"12","author":"Lee","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0660","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1038\/s41467-026-73822-6","article-title":"Self-assembled chamber-like cardiac organoids for modeling cardiac chamber formation and cardiotoxicity assessment","volume":"17","author":"Zou","year":"2026","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112926_bb0665","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/s44161-025-00669-3","article-title":"Maturation of human cardiac organoids enables complex disease modeling and drug discovery","volume":"4","author":"Pocock","year":"2025","journal-title":"Nat. Cardiovasc. Res"},{"key":"10.1016\/j.cellsig.2026.112926_bb0670","article-title":"Sacubitril\/valsartan reduces proteasome activation and cardiomyocyte area in an experimental mouse model of hypertrophy","volume":"7","author":"Meyer-Jens","year":"2024","journal-title":"J. Mol. Cell. Cardiol. Plus."},{"key":"10.1016\/j.cellsig.2026.112926_bb0675","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1229960","article-title":"Evaluation of chronic drug-induced electrophysiological and cytotoxic effects using human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)","volume":"14","author":"Altrocchi","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"20","key":"10.1016\/j.cellsig.2026.112926_bb0680","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1161\/CIRCULATIONAHA.121.058621","article-title":"Olmesartan Restores LMNA Function in Haploinsufficient Cardiomyocytes","volume":"151","author":"Kort","year":"2025","journal-title":"Circulation"},{"issue":"7769","key":"10.1016\/j.cellsig.2026.112926_bb0685","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41586-019-1406-x","article-title":"Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy","volume":"572","author":"Lee","year":"2019","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.cellsig.2026.112926_bb0690","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1016\/j.stemcr.2021.08.018","article-title":"Antihypertensive drug treatment and susceptibility to SARS-CoV-2 infection in human PSC-derived cardiomyocytes and primary endothelial cells","volume":"16","author":"Iwanski","year":"2021","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.cellsig.2026.112926_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119741","article-title":"Human cardiac fibrosis-on-a-chip model recapitulates disease hallmarks and can serve as a platform for drug testing","volume":"233","author":"Mastikhina","year":"2020","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0700","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1038\/s41467-024-46928-y","article-title":"Versatile human cardiac tissues engineered with perfusable heart extracellular microenvironment for biomedical applications","volume":"15","author":"Min","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0705","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13287-026-05079-1","article-title":"iPSC-derived cardiac organoids for drug cardiotoxicity evaluation and efficacy prediction in myocardial infarction and cardiac hypertrophy models","volume":"17","author":"Hou","year":"2026","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.cellsig.2026.112926_bb0710","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2019.03.003","article-title":"The arrhythmogenic potential of nerve agents and a cardiac safety profile of antidotes - A proof-of-concept study using human induced pluripotent stem cells derived cardiomyocytes (hiPSC-CM)","volume":"308","author":"Amend","year":"2019","journal-title":"Toxicol. Lett."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112926_bb0715","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1161\/CIRCULATIONAHA.111.045146","article-title":"Human embryonic and induced pluripotent stem cell-derived cardiomyocytes exhibit beat rate variability and power-law behavior","volume":"125","author":"Mandel","year":"2012","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112926_bb0720","doi-asserted-by":"crossref","DOI":"10.3390\/biom13040676","article-title":"Does Enhanced Structural Maturity of hiPSC-Cardiomyocytes Better for the Detection of Drug-Induced Cardiotoxicity?","volume":"13","author":"Van de Sande","year":"2023","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112926_bb0725","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.stemcr.2018.10.008","article-title":"Atrial-like Engineered Heart Tissue: An In Vitro Model of the Human Atrium","volume":"11","author":"Lemme","year":"2018","journal-title":"Stem Cell Reports"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112926_bb0730","doi-asserted-by":"crossref","first-page":"394","DOI":"10.15252\/emmm.201404757","article-title":"Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology","volume":"7","author":"Devalla","year":"2015","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0735","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41467-019-13868-x","article-title":"Generating ring-shaped engineered heart tissues from ventricular and atrial human pluripotent stem cell-derived cardiomyocytes","volume":"11","author":"Goldfracht","year":"2020","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112926_bb0740","first-page":"27","article-title":"Promoting differentiation of human-induced pluripotent stem cells into sinoatrial node-like cells through programmed regulation of AMPK signalling pathway","author":"Liu","year":"2025","journal-title":"EP Europace"},{"issue":"23","key":"10.1016\/j.cellsig.2026.112926_bb0745","doi-asserted-by":"crossref","DOI":"10.3390\/cells11233764","article-title":"Impact of Neurons on Patient-Derived Cardiomyocytes Using Organ-On-A-Chip and iPSC Biotechnologies","volume":"11","author":"Bernardin","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0750","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.1038\/s41467-022-34860-y","article-title":"A soft and ultrasensitive force sensing diaphragm for probing cardiac organoids instantaneously and wirelessly","volume":"13","author":"Lyu","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0755","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.scr.2010.09.001","article-title":"Endothelin-1 and angiotensin II modulate rate and contraction amplitude in a subpopulation of mouse embryonic stem cell-derived cardiomyocyte-containing bodies","volume":"6","author":"Lagerqvist","year":"2011","journal-title":"Stem Cell Res."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112926_bb0760","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1097\/00004872-198900076-00044","article-title":"Endothelin has potent direct inotropic and chronotropic effects in cultured heart cells","volume":"7","author":"Concas","year":"1989","journal-title":"J. Hypertens. Suppl."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112926_bb0765","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1161\/01.CIR.94.7.1752","article-title":"Postischemic antiarrhythmic effects of angiotensin-converting enzyme inhibitors. Role of suppression of endogenous endothelin secretion","volume":"94","author":"Brunner","year":"1996","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0770","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0022-3565(24)35311-X","article-title":"Contractile and Arrhythmic Effects of Endothelin Receptor Agonists in Human Heart In Vitro: Blockade with SB 2096701","volume":"292","author":"Burrell","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112926_bb0775","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/01.RES.0000172556.05576.4c","article-title":"Endothelin-1-induced arrhythmogenic Ca2+ signaling is abolished in atrial myocytes of inositol-1,4,5-trisphosphate(IP3)-receptor type 2-deficient mice","volume":"96","author":"Li","year":"2005","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112926_bb0780","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108051","article-title":"RNA expression profiling of human iPSC-derived cardiomyocytes in a cardiac hypertrophy model","volume":"9","author":"Aggarwal","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112926_bb0785","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1186\/s13287-022-03215-1","article-title":"Robust generation of human-chambered cardiac organoids from pluripotent stem cells for improved modelling of cardiovascular diseases","volume":"13","author":"Ho","year":"2022","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112926_bb0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.167861","article-title":"Modeling heart failure by induced pluripotent stem cell-derived organoids","volume":"1871","author":"Bissoli","year":"2025","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112926_bb0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112322","article-title":"Vascular cells improve functionality of human cardiac organoids","volume":"42","author":"Voges","year":"2023","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112926_bb0800","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1016\/j.apsb.2024.06.023","article-title":"Genome-wide pan-GPCR cell libraries accelerate drug discovery","volume":"14","author":"Yang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112926_bb0805","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1253\/circj.CJ-12-0987","article-title":"Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture","volume":"77","author":"Kamakura","year":"2013","journal-title":"Circ. J."},{"issue":"14","key":"10.1016\/j.cellsig.2026.112926_bb0810","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1089\/scd.2012.0490","article-title":"Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells","volume":"22","author":"Lundy","year":"2013","journal-title":"Stem Cells Dev."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112926_bb0815","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1096\/fj.15-280982","article-title":"Time-dependent evolution of functional vs. remodeling signaling in induced pluripotent stem cell-derived cardiomyocytes and induced maturation with biomechanical stimulation","volume":"30","author":"Jung","year":"2016","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112926_bb0820","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.3390\/cells9102275","article-title":"Age-Dependent Maturation of iPSC-CMs Leads to the Enhanced Compartmentation of \u03b22AR-cAMP Signalling","volume":"9","author":"Hasan","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112926_bb0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107925","article-title":"Metabolic Maturation Media Improve Physiological Function of Human iPSC-Derived Cardiomyocytes","volume":"32","author":"Feyen","year":"2020","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112926_bb0830","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.stemcr.2022.07.006","article-title":"Physiological calcium combined with electrical pacing accelerates maturation of human engineered heart tissue","volume":"17","author":"Shen","year":"2022","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.cellsig.2026.112926_bb0835","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.710619","article-title":"Substrate Stiffness Influences Structural and Functional Remodeling in Induced Pluripotent Stem Cell-Derived Cardiomyocytes","volume":"12","author":"K\u00f6rner","year":"2021","journal-title":"Front. Physiol."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112926_bb0840","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/eurheartj\/ehad841","article-title":"Human heart organoids: current applications and future perspectives","volume":"45","author":"Kostina","year":"2024","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112926_bb0845","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.stemcr.2023.06.001","article-title":"Vascularized hiPSC-derived 3D cardiac microtissue on chip","volume":"18","author":"Arslan","year":"2023","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.cellsig.2026.112926_bb0850","article-title":"Heart and kidney organoids maintain organ-specific function in a microfluidic system","volume":"23","author":"Gabbin","year":"2023","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.cellsig.2026.112926_bb0855","first-page":"122","article-title":"Engineering a multi-organ chip to explore heart-brain crosstalk in health and pathology","author":"Schwach","year":"2026","journal-title":"Cardiovasc. Res."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112926_bb0860","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"554","key":"10.1016\/j.cellsig.2026.112926_bb0865","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax9276","article-title":"Clinical trial in a dish using iPSCs shows lovastatin improves endothelial dysfunction and cellular cross-talk in LMNA cardiomyopathy","volume":"12","author":"Sayed","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112926_bb0870","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/cts.12674","article-title":"Clinical Trial in a Dish: Personalized Stem Cell-Derived Cardiomyocyte Assay Compared With Clinical Trial Results for Two QT-Prolonging Drugs","volume":"12","author":"Blinova","year":"2019","journal-title":"Clin Transl Sci"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826005851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826005851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:28:41Z","timestamp":1791660521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826005851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":174,"alternative-id":["S0898656826005851"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112926","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging the gap: combining GPCR-based drug discovery with iPSC-based cardiovascular disease modeling in a dish","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112926","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112926"}}